No Data
No Data
Morgan Stanley Maintains ICL Group(ICL.US) With Hold Rating, Cuts Target Price to $4.9
Public Companies Invested in ICL Group Ltd (NYSE:ICL) Copped the Brunt of Last Week's US$323m Market Cap Decline
The Return Trends At ICL Group (NYSE:ICL) Look Promising
ICL Group Updates Executive Compensation Policy
ICL Announced It Has Signed A MoU With Orbia Advance Corp., S.A.B. De C.V. Fluor & Energy Materials, As Both Companies Continue To Expand Their Presence In The North American Battery Materials Supply Chain
SeaStar Medical Reports Strong Enrollment Progress In Pivotal Adult AKI Trial With 46 Total Subjects Enrolled; Trial Evaluates Safety And Efficacy Of Selective Cytopheretic Device For Acute Kidney Injury Patients In ICU